150 related articles for article (PubMed ID: 22464339)
1. European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings.
Schosser A; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Jul; 22(7):453-68. PubMed ID: 22464339
[TBL] [Abstract][Full Text] [Related]
2. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
4. Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice.
Bartova L; Dold M; Kautzky A; Fabbri C; Spies M; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Schosser A; Kasper S
World J Biol Psychiatry; 2019 Jul; 20(6):427-448. PubMed ID: 31340696
[No Abstract] [Full Text] [Related]
5. The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.
Kautzky A; Baldinger P; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Eur Neuropsychopharmacol; 2015 Apr; 25(4):441-53. PubMed ID: 25769916
[TBL] [Abstract][Full Text] [Related]
6. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
7. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
8. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.
Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
Acta Psychiatr Scand; 2019 Jan; 139(1):78-88. PubMed ID: 30291625
[TBL] [Abstract][Full Text] [Related]
9. Using adjunctive treatments when first-line antidepressants fail.
Thase ME
J Clin Psychiatry; 2012 Jan; 73(1):e01. PubMed ID: 22316580
[TBL] [Abstract][Full Text] [Related]
10. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
Schosser A; Kasper S
Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
[TBL] [Abstract][Full Text] [Related]
11. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
12. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137
[TBL] [Abstract][Full Text] [Related]
14. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
[TBL] [Abstract][Full Text] [Related]
15. Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Souery D; Serretti A; Calati R; Oswald P; Massat I; Konstantinidis A; Linotte S; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Zohar J; Mendlewicz J
J Clin Psychopharmacol; 2011 Aug; 31(4):512-6. PubMed ID: 21694617
[TBL] [Abstract][Full Text] [Related]
16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
17. Treatment-resistant depression in adolescents: review and updates on clinical management.
Maalouf FT; Atwi M; Brent DA
Depress Anxiety; 2011 Nov; 28(11):946-54. PubMed ID: 21898710
[TBL] [Abstract][Full Text] [Related]
18. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
[TBL] [Abstract][Full Text] [Related]
19. Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.
Nakajima S; Ishida T; Akaishi R; Takahata K; Kitahata R; Uchida H; Suzuki T; Takeuchi H; Nomura K; Nakagawa A; Watanabe K; Kashima H
J ECT; 2009 Sep; 25(3):178-81. PubMed ID: 19710625
[TBL] [Abstract][Full Text] [Related]
20. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
